Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SI-BONE, Inc. Director's Dealing 2020

Aug 19, 2020

32647_dirs_2020-08-19_5e7fe503-06e4-469e-94df-dc9a01013834.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2020-08-17

Reporting Person: FRANCIS LAURA (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-17 Common Stock S 494.00 $20.8293 Disposed 137796.00 Direct
2020-08-17 Common Stock S 1171.00 $20.8293 Disposed 136625.00 Direct
2020-08-17 Common Stock S 433.00 $20.8293 Disposed 136192.00 Direct
2020-08-17 Common Stock M 7553.00 $4.32 Acquired 143745.00 Direct
2020-08-17 Common Stock M 2418.00 $4.68 Acquired 146163.00 Direct
2020-08-17 Common Stock S 7553.00 $21.0444 Disposed 138610.00 Direct
2020-08-17 Common Stock S 2418.00 $21.0444 Disposed 136192.00 Direct
2020-08-18 Common Stock M 8029.00 $4.32 Acquired 144221.00 Direct
2020-08-18 Common Stock S 8029.00 $21.0444 Disposed 136192.00 Direct
2020-08-18 Common Stock S 931.00 $20.6396 Disposed 135261.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-17 Stock Option (Right to Buy) $4.68 M 2418.00 Disposed 2027-03-01 Common Stock (2418.00) Direct
2020-08-17 Stock Option (Right to Buy) $4.32 M 7553.00 Disposed 2025-05-25 Common Stock (7553.00) Direct
2020-08-18 Stock Option (Right to Buy) $4.32 M 8029.00 Disposed 2025-05-25 Common Stock (8029.00) Direct

Footnotes

F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.36, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F4: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.51 to $20.94, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F5: Includes 80,080 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

F6: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.